Our mission is to provide our customers and our partners with the best quality membrane targets/antigens for their discovery projects in order to develop more reliable and better performing drug and vaccine candidates for a better health for all.
Isolate and stabilize native membrane protein targets starting from any biological material
Our innovative technologies and approaches allow the deorphanization, identification of new targets / antigens and their isolation in the highest quality conditions for conformational antibody development, vaccine development, high-throughput screening (HTS) of ligands, structure-based drug discovery, assays and immunoassays.
Our know-how and technological platform are relevant to downstream processing (DSP) as well as upstream processing (USP – expression part) applications and detergent quantification.
To learn more about our process see Technology Platform or Case Studies.